Literature DB >> 182204

Molecular mechanism of cardiotoxin action on axonal membranes.

J P Vincent, H Schweitz, R Chicheportiche, M Fosset, M Balerna, M C Lenoir, M Lazdunski.   

Abstract

Cardiotoxin isolated from Naja mossambica mossambica selectively deactivates the sodium-potassium activated adenosine triphosphatase of axonal membranes. Tetrodotoxin binding and acetylcholinesterase activities are unaffected by cardiotoxin treatment. The details of association of cardiotoxin with the axonal membrane were studied by following the deactivation of the sodium-potassium activated adenosine triphosphatase and by direct binding measurements with a tritiated derivative of the native cardiotoxin. The maximal binding capacity of the membrane is 42-50 nmol of cardiotoxin/mg of membrane protein. The high amount of binding suggests association of the toxin with the lipid phase of the membrane. It has been shown that cardiotoxin first associates rapidly and reversibly to membrane lipids, then, in a second step, it induces a rearrangement of the membrane structure which produces and irreversible deactivation of the sodium-potassium activated adenosine triphosphatase. Solubilization of the membrane-bound ATPase with Lubrol WX gives an active enzyme species that is resistant to cardiotoxin-induced deactivation. Cardiotoxin binding to the membrane is prevented by high concentrations of Ca 2+ and dibucaine. Although cardiotoxins and neurotoxins of cobra venom have large sequence homologies, their mode of action on membranes is very different. The cardiotoxin seems to bind to the lipid phase of the axonal membrane and inhibits the sodium-potassium activated adenosine triphosphatase, whereas the neurotoxin associates with a protein receptor in the post-synaptic membrane and blocks acetylcholine transmission.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182204     DOI: 10.1021/bi00660a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Crystal structure of a snake venom cardiotoxin.

Authors:  B Rees; J P Samama; J C Thierry; M Gilibert; J Fischer; H Schweitz; M Lazdunski; D Moras
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

2.  Snake venom cardiotoxin can rapidly induce actin polymerization in intact platelets.

Authors:  R F Liou; W C Chang; S T Chu; Y H Chen
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

3.  Model of interaction between a cardiotoxin and dimyristoylphosphatidic acid bilayers determined by solid-state 31P NMR spectroscopy.

Authors:  F Picard; M Pézolet; P E Bougis; M Auger
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

4.  Interaction of snake venom cardiotoxin (a membrane-disruptive polypeptide) with human erythrocytes.

Authors:  Y H Chen; R F Liou; C T Hu; C C Juan; J T Yang
Journal:  Mol Cell Biochem       Date:  1987-01       Impact factor: 3.396

5.  Are interactions with phospholipids responsible for pharmacological activities of cardiotoxins?

Authors:  P Bougis; M Tessier; J Van Rietschoten; H Rochat; J F Faucon; J Dufourcq
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.